Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States

Background/Aims Harmful alcohol use is a substantial contributor to liver diseases, liver cancer, and extrahepatic neoplasms. Patterns of alcohol consumption have shifted over recent decades. This study evaluates trends in alcohol-associated liver disease (ALD) and alcohol-attributable cancers in th...

書誌詳細
出版年:	Clinical and Molecular Hepatology
主要な著者:	Pojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, Primrose Tothanarungroj, Luis Antonio Díaz, Juan Pablo Arab, Pimtawan Jatupornpakdee, Mark D. Muthiah, Kwanjit Duangsonk, Won-Mook Choi, Daniel Q. Huang, Donghee Kim, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul, Amit G. Singal, Ju Dong Yang
フォーマット:	論文
言語:	英語
出版事項:	Korean Association for the Study of the Liver 2025-07-01
主題:	alcohol chronic liver disease steatotic liver disease sex disparity
オンライン･アクセス:	http://e-cmh.org/upload/pdf/cmh-2025-0169.pdf

類似資料

Hydrophilic and lipophilic statin and clinical outcomes in individuals with alcohol-associated liver disease
著者:: Pojsakorn Danpanichkul, 等
出版事項: (2025-07-01)

Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
著者:: Donghee Kim, 等
出版事項: (2024-10-01)

Changes in the epidemiological trends of primary liver cancer in the Asia–Pacific region
著者:: Pojsakorn Danpanichkul, 等
出版事項: (2024-08-01)

Correspondence to editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021”
著者:: Pojsakorn Danpanichkul, 等
出版事項: (2025-04-01)

Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
著者:: Pojsakorn Danpanichkul, 等
出版事項: (2025-04-01)

Contemporary burden of mortality from chronic liver disease by sex and race/ethnicity in the United States
著者:: Donghee Kim, 等
出版事項: (2025-07-01)

Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
著者:: Donghee Kim, 等
出版事項: (2025-04-01)

Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
著者:: Pojsakorn Danpanichkul, 等
出版事項: (2025-01-01)

Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake
著者:: Emil Deleuran Hansen, 等
出版事項: (2025-01-01)

Metabolic outcomes in non-alcoholic and alcoholic steatotic liver disease among Korean and American adults
著者:: Yeongmin Kim, 等
出版事項: (2025-02-01)

Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
著者:: Katharina Staufer, 等
出版事項: (2023-07-01)

Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes
著者:: Hiroyuki Ito, 等
出版事項: (2025-06-01)

Phosphatidylethanol and ethyl glucuronide to categorize alcohol consumption in alcohol-related cirrhosis
著者:: Benedict T.K. Vanlerberghe, 等
出版事項: (2025-08-01)

Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly
著者:: Pojsakorn Danpanichkul, 等
出版事項: (2024-04-01)

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
著者:: Karn Wijarnpreecha, 等
出版事項: (2021-04-01)

Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?
著者:: Doaa El Amrousy, 等
出版事項: (2024-11-01)

ALT levels, alcohol use, and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population
著者:: Ville Männistö, 等
出版事項: (2024-10-01)

Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use
著者:: Shyam Patel, 等
出版事項: (2024-01-01)

Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption
著者:: Mubin Ozercan, 等
出版事項: (2025-01-01)

Liver Stiffness, Not Steatosis, Predicts Mortality in MASLD Patients: An NHANES Analysis
著者:: Yuting Huang, 等
出版事項: (2024-12-01)

Treatment of HCV infection in patients with steatotic liver disease
著者:: Robert Flisiak, 等
出版事項: (2024-07-01)

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
著者:: Yuri Cho
出版事項: (2024-11-01)

Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study
著者:: Michihiro Iwaki, 等
出版事項: (2024-04-01)

Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
著者:: Minkwan Kim, 等
出版事項: (2025-07-01)

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study
著者:: Woo-Young Shin, 等
出版事項: (2025-04-01)

Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases
著者:: Madan Kumar Arumugam, 等
出版事項: (2023-10-01)

Platelets in Alcohol-Associated Liver Disease: Interaction With NeutrophilsSummary
著者:: Juan Wang, 等
出版事項: (2024-01-01)

A new Korean nomenclature for steatotic liver disease
著者:: Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
出版事項: (2024-09-01)

Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease
著者:: In-gyu Park, 等
出版事項: (2024-07-01)

The evolution of artificial intelligence technology in non-alcoholic fatty liver disease
著者:: Jiawen He, 等
出版事項: (2025-09-01)

Serum metabolites characterize hepatic phenotypes and reveal shared pathways: results from population-based imaging
著者:: Juliane Maushagen, 等
出版事項: (2025-07-01)

The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients
著者:: Alexander S. Vogel, 等
出版事項: (2024-05-01)

Misclassification of Alcohol Use Disorder in MASLD and MetALD: Prevalence, Clinical Characteristics, and Outcomes
著者:: Jun-Hyuk Lee, 等
出版事項: (2025-09-01)

Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites
著者:: Dongliang Chen, 等
出版事項: (2024-04-01)

Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study
著者:: Qiaoling Wu, 等
出版事項: (2025-01-01)

Older adults living with gastrointestinal cancers in 2021
著者:: Pojsakorn Danpanichkul, 等
出版事項: (2025-06-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
著者:: K. L. Raikhelson, 等
出版事項: (2024-05-01)

Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
著者:: Tsubasa Tsutsumi, 等
出版事項: (2024-04-01)

Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing System, Cytochrome P450 2E1, Catalase, and Aldehyde Dehydrogenase in Alcohol-Associated Liver Disease
著者:: Yanchao Jiang, 等
出版事項: (2020-03-01)

Corrigendum: Pyroptosis and gasdermins—Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis
著者:: Christian Stoess, 等
出版事項: (2024-10-01)